Advertisement
Advertisement
U.S. markets open in 1 hour 27 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.3100+0.1000 (+8.26%)
At close: 04:00PM EDT
1.3100 0.00 (0.00%)
Pre-Market: 08:00AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close1.2100
Open1.1900
Bid0.0000 x 4000
Ask0.0000 x 3000
Day's Range1.1900 - 1.3100
52 Week Range0.7280 - 19.1400
Volume201,506
Avg. Volume417,343
Market Cap34.37M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-4.0020
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for APLT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Applied Therapeutics, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    10 months agoMorningstar
View more
  • GlobeNewswire

    Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference

    Gold sponsor of the 2022 Galactosemia Foundation Conference; new website and educational resources as part of ongoing commitment to the Galactosemia communityApplied Therapeutics to present research and clinical update NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced its spons

  • GlobeNewswire

    Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants

    NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricing of its underwritten public offering of 20.0 million shares of its common stock, par value $0.0001 per share, 10.0 million pre-funded warrants to purchase common stock in lieu of common stock to certai

  • GlobeNewswire

    Applied Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants

    NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it plans to make a public offering of shares of its common stock, par value $0.0001 per share, or pre-funded warrants to purchase common stock in lieu of common stock to certain investors, and accompanying w

Advertisement
Advertisement